Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2009;41(2):128-38.
doi: 10.1080/07853890802337037.

Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index

Cornelia Huth  1 , Thomas Illig, Christian Herder, Christian Gieger, Harald Grallert, Caren Vollmert, Wolfgang Rathmann, Yasmin H Hamid, Oluf Pedersen, Torben Hansen, Barbara Thorand, Christa Meisinger, Angela Doring, Norman Klopp, Henning Gohlke, Wolfgang Lieb, Christian Hengstenberg, Valeriya Lyssenko, Leif Groop, Helen Ireland, Jeffrey W Stephens, Ingrid Wernstedt Asterholm, John-Olov Jansson, Heiner Boeing, Matthias Mohlig, Heather M Stringham, Michael Boehnke, Jaakko Tuomilehto, Jose-Manuel Fernandez-Real, Abel Lopez-Bermejo, Luis Gallart, Joan Vendrell, Steve E Humphries, Florian Kronenberg, H-Erich Wichmann, Iris M Heid
Affiliations
Meta-Analysis

Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index

Cornelia Huth et al. Ann Med. 2009.

Abstract

Background: Several studies have investigated associations between the -174G>C single nucleotide polymorphism (rs1800795) of the IL6 gene and phenotypes related to type 2 diabetes mellitus (T2DM) but presented inconsistent results.

Aims: This joint analysis aimed to clarify whether IL6 -174G>C was associated with glucose and circulating interleukin-6 concentrations as well as body mass index (BMI).

Methods: Individual-level data from all studies of the IL6-T2DM consortium on Caucasian subjects with available BMI were collected. As study-specific estimates did not show heterogeneity (P>0.1), they were combined by using the inverse-variance fixed-effect model.

Results: The main analysis included 9440, 7398, 24,117, or 5659 non-diabetic and manifest T2DM subjects for fasting glucose, 2-hour glucose, BMI, or circulating interleukin-6 levels, respectively. IL6 -174 C-allele carriers had significantly lower fasting glucose (-0.091 mmol/L, P=0.014). There was no evidence for association between IL6 -174G>C and BMI or interleukin-6 levels, except in some subgroups.

Conclusions: Our data suggest that C-allele carriers of the IL6 -174G>C polymorphism have lower fasting glucose levels on average, which substantiates previous findings of decreased T2DM risk of these subjects.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
See this image and copyright information in PMC

References

    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. - PubMed
    1. Das SK, Elbein SC. The Genetic Basis of Type 2 Diabetes. Cellscience. 2006;2:100–131. - PMC - PubMed
    1. Carey AL, Bruce CR, Sacchetti M, et al. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia. 2004;47:1029–1037. - PubMed
    1. Andreozzi F, Laratta E, Cardellini M, et al. Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Diabetes. 2006;55:2021–2024. - PubMed
    1. Henningsson S, Hakansson A, Westberg L, et al. Interleukin-6 gene polymorphism -174G/C influences plasma lipid levels in women. Obesity. 2006;14:1868–1873. - PubMed

Publication types